Back
Fate Therapeutics, Inc. Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
34
FATE
Fate Therapeutics, Inc.
Last Price:
$0.99
Seasonality Move:
30.36%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and FATE is experiencing slight selling pressure.
Fate Therapeutics, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.07 | Sell |
| 20-day SMA: | 1.07 | Sell |
| 50-day SMA: | 1.19 | Sell |
| 200-day SMA: | 1.13 | Sell |
| 8-day EMA: | 1.05 | Sell |
| 20-day EMA: | 1.07 | Sell |
| 50-day EMA: | 1.02 | Sell |
| 200-day EMA: | 0.53 | Buy |
Fate Therapeutics, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.01 | Sell |
| Relative Strength Index (14 RSI): | 42.19 | Sell |
| Chaikin Money Flow: | -263858 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.03 - 1.11) | Sell |
| Bollinger Bands (100): | (0.95 - 1.33) | Sell |
Fate Therapeutics, Inc. Technical Analysis
| Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Fate Therapeutics, Inc. Stock
Is Fate Therapeutics, Inc. Stock a Buy?
-
Fate Therapeutics, Inc. share price is 1.01 while FATE 8-day simple moving average is 1.07, which is a Sell signal.
-
The stock price of FATE is 1.01 while Fate Therapeutics, Inc. 20-day SMA is 1.07, which makes it a Sell.
-
Fate Therapeutics, Inc. 50-day simple moving average is 1.19 while FATE share price is 1.01, making it a Sell technically.
-
FATE stock price is 1.01 and Fate Therapeutics, Inc. 200-day simple moving average is 1.13, creating a Sell signal.
FATE Technical Analysis vs Fundamental Analysis
Sell
34
Fate Therapeutics, Inc. (FATE)
is a Sell
Is Fate Therapeutics, Inc. a Buy or a Sell?
-
Fate Therapeutics, Inc. stock is rated a SellThe current Fate Therapeutics, Inc. [FATE] share price is $1.01. The Score for FATE is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
Fate Therapeutics, Inc. Stock Info
Market Cap:
116.5M
Price in USD:
1.01
Share Volume:
791.6K
Fate Therapeutics, Inc. 52-Week Range
52-Week High:
1.99
52-Week Low:
0.66
Sell
34
Fate Therapeutics, Inc. (FATE)
is a Sell
Fate Therapeutics, Inc. Share Price Forecast
-
What is the Fate Therapeutics, Inc. stock price today?The Fate Therapeutics, Inc. stock price is 1.01 USD today.
-
Will FATE stock go up or go down?Fate Therapeutics, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Fate Therapeutics, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Fate Therapeutics, Inc. is overvalued.
Is Fate Therapeutics, Inc. Stock a Buy?
-
Fate Therapeutics, Inc. share price is 1.01 while FATE 8-day exponential moving average is 1.05, which is a Sell signal.
-
The stock price of FATE is 1.01 while Fate Therapeutics, Inc. 20-day EMA is 1.07, which makes it a Sell.
-
Fate Therapeutics, Inc. 50-day exponential moving average is 1.02 while FATE share price is 1.01, making it a Sell technically.
-
FATE stock price is 1.01 and Fate Therapeutics, Inc. 200-day simple moving average is 0.53, creating a Buy signal.
Fundamental Analysis of Fate Therapeutics, Inc.
Is Fate Therapeutics, Inc. a good investment?
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.43 per share, and a decrease next year of $0.01 per share.
Technical Analysis of Fate Therapeutics, Inc.
Should I short Fate Therapeutics, Inc. stock?
-
FATE Moving Average Covergence Divergence (MACD) indicator is -0.01, suggesting Fate Therapeutics, Inc. is a Sell
-
Fate Therapeutics, Inc. Relative Strength Index (RSI) is 42.19, which suggest Fate Therapeutics, Inc. is oversold
-
The Bollinger Bands (25) for Fate Therapeutics, Inc. is (1.03 - 1.11), which suggest Fate Therapeutics, Inc. is a Sell
-
The Bollinger Bands (100) for Fate Therapeutics, Inc. is (0.95 - 1.33), which suggest Fate Therapeutics, Inc. is a Sell
* Fate Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.